InvestLog
KPTI Karyopharm Therapeutics Inc. logo

KPTI Karyopharm Therapeutics Inc.

Healthcare
$8.97+0.00%OpenMarket Cap: $76.5M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

6

Dispositions

7

Buy/Sell Ratio

0.86

Net Shares

+4,425

Shares Acquired

8,531

Shares Disposed

4,106

Total Bought ($)

$0.00

Total Sold ($)

$7.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 15Rangwala Reshmaofficer: EVP & Chief Medical OfficerSell408$9.5056,829
Fri May 15Rangwala Reshmaofficer: EVP & Chief Medical OfficerSell947$0.0057,237
Fri May 15Poulton Stuartofficer: EVP, Chief Development OfficerSell403$9.5094,821
Fri May 15Poulton Stuartofficer: EVP, Chief Development OfficerSell896$0.0095,224
Fri May 15Paulson Richard A.director, officer: President and CEOSell2,203$9.50269,747
Fri May 15Paulson Richard A.director, officer: President and CEOSell4,920$0.00271,950
Fri May 15Cheng Sohanya Roshanofficer: EVP & Chief Commercial OfficerSell324$9.50107,940
Fri May 15Cheng Sohanya Roshanofficer: EVP & Chief Commercial OfficerSell947$0.00108,264
Fri May 15Abate Kristinofficer: Chief Accounting OfficerSell53$9.5023,801
Fri May 15Abate Kristinofficer: Chief Accounting OfficerSell121$0.0023,854
Wed Apr 22Rangwala Reshmaofficer: EVP & Chief Medical OfficerSell449$8.9456,290
Tue Mar 03Rangwala Reshmaofficer: EVP & Chief Medical OfficerSell5,066$9.4156,739
Tue Mar 03Poulton Stuartofficer: EVP, Chief Development OfficerSell5,101$9.4194,328
Tue Mar 03Paulson Richard A.director, officer: President and CEOSell12,361$9.41267,030
Tue Mar 03Mano Michaelofficer: EVP, CLO&SecretarySell3,526$9.4193,964